Compare ADMA Biologics Inc (ADMA) vs American Tower Corp (AMT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ADMA Biologics Inc vs American Tower Corp — how do they compare? ADMA Biologics Inc trades at $9.81 (market cap $2.22B), while American Tower Corp trades at $169 (market cap $79.00B). The key difference: American Tower Corp is far larger — about 35.6× ADMA Biologics Inc's market cap, and American Tower Corp pays a 4.12% dividend while ADMA Biologics Inc pays none. Which is the better fit depends on your goals.
| ADMA | AMT | |
|---|---|---|
Market Cap | $2.22B | $79.00B |
Sector | Health | Real Estate |
52-Week High | $20.38 | $211.88 |
52-Week Low | $7.60 | $162.11 |
Enterprise Value | $2.29B | $122.53B |
Dividend Yield | — | 4.12% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ADMA Biologics Inc
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Read more on ADMA →About American Tower Corp
American Tower owns and operates more than 220,000 cell towers throughout the U.S., Asia, Latin America, Europe, and Africa. It also owns and/or operates 25 data centers in eight U.S. markets after acquiring CoreSite. On its towers, the company has a very concentrated customer base, with most revenue in each market being generated by just the top few mobile carriers. The company operates more than 40,000 towers in the U.S., which accounted for more than half of its total revenue in 2021. Outside the U.S., American Tower's greatest presence is in India and Brazil, where it operates roughly 75,000 and 19,000 towers, respectively. American Tower operates as a real estate investment trust.
Read more on AMT →
